These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18190624)

  • 21. Long-term results of sacral neuromodulation for women with urinary retention.
    Dasgupta R; Wiseman OJ; Kitchen N; Fowler CJ
    BJU Int; 2004 Aug; 94(3):335-7. PubMed ID: 15291863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and predictors of complications with sacral neuromodulation.
    White WM; Mobley JD; Doggweiler R; Dobmeyer-Dittrich C; Klein FA
    Urology; 2009 Apr; 73(4):731-5. PubMed ID: 19193415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sacral nerve stimulation in fecal incontinence: are there factors associated with success?
    Gourcerol G; Gallas S; Michot F; Denis P; Leroi AM
    Dis Colon Rectum; 2007 Jan; 50(1):3-12. PubMed ID: 17080278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up.
    Ghazwani YQ; Elkelini MS; Hassouna MM
    Neurourol Urodyn; 2011 Sep; 30(7):1271-5. PubMed ID: 21557299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women.
    Borawski KM; Foster RT; Webster GD; Amundsen CL
    Neurourol Urodyn; 2007; 26(1):14-8. PubMed ID: 17123297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurosurgical treatment of hyperactive bladder in spinal cord injury patients].
    Bauchet L; Segnarbieux F; Martinazzo G; Frerebeau P; Ohanna F
    Neurochirurgie; 2001 Feb; 47(1):13-24. PubMed ID: 11283451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming requirements after sacral nerve stimulator implantation: correlation with preoperative indication.
    Maxwell KM; Clemens JQ; Mazzenga L; Kielb SJ
    J Urol; 2008 Feb; 179(2):549-51. PubMed ID: 18076913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?
    Kessler TM; Madersbacher H; Kiss G
    Eur Urol; 2005 May; 47(5):660-5. PubMed ID: 15826759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary results of sacral neuromodulation in 23 children.
    Humphreys MR; Vandersteen DR; Slezak JM; Hollatz P; Smith CA; Smith JE; Reinberg YE
    J Urol; 2006 Nov; 176(5):2227-31. PubMed ID: 17070300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of MRI at 1.5Tesla in patients with implanted sacral nerve neurostimulator.
    Elkelini MS; Hassouna MM
    Eur Urol; 2006 Aug; 50(2):311-6. PubMed ID: 16530923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of sacral nerve stimulation due to migration of tined lead.
    Deng DY; Gulati M; Rutman M; Raz S; Rodríguez LV
    J Urol; 2006 Jun; 175(6):2182-5. PubMed ID: 16697835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis.
    Peters KM; Konstandt D
    BJU Int; 2004 Apr; 93(6):777-9. PubMed ID: 15049989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sacral neuromodulation in urology - development and current status].
    Schwalenberg T; Stolzenburg JU; Kriegel C; Gonsior A
    Aktuelle Urol; 2012 Jan; 43(1):39-48. PubMed ID: 22271337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sacral neuromodulation for nonobstructive urinary retention--is success predictable?
    Goh M; Diokno AC
    J Urol; 2007 Jul; 178(1):197-9; discussion 199. PubMed ID: 17499773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sacral nerve stimulation for faecal incontinence: long-term outcome.
    Matzel KE; Lux P; Heuer S; Besendörfer M; Zhang W
    Colorectal Dis; 2009 Jul; 11(6):636-41. PubMed ID: 18727721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of percutaneous tibial nerve stimulation for different types of lower urinary tract dysfunction in children.
    Capitanucci ML; Camanni D; Demelas F; Mosiello G; Zaccara A; De Gennaro M
    J Urol; 2009 Oct; 182(4 Suppl):2056-61. PubMed ID: 19695611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction.
    Pham K; Guralnick ML; O'Connor RC
    Neurourol Urodyn; 2008; 27(8):779-81. PubMed ID: 18551562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation.
    Everaert K; Kerckhaert W; Caluwaerts H; Audenaert M; Vereecke H; De Cuypere G; Boelaert A; Van den Hombergh U; Oosterlinck W
    Eur Urol; 2004 May; 45(5):649-54. PubMed ID: 15082209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure.
    Maher MG; Mourtzinos A; Zabihi N; Laiwalla UZ; Raz S; Rodríguez LV
    J Urol; 2007 Jun; 177(6):2237-40; discussion 2241. PubMed ID: 17509329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.